From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotech stocks generally did well on Tuesday as the Nasdaq Biotech Index (^NBI) gained 0.11% to 831.94. Cerus (CERS) gained more than 12% after the company received…
Biotechnology CYTRX CP +12.90% INTROGEN THERAPEU +10.95% SENESCO TECH +10.37% IDERA PHARMACEUTICAL +10.00% CYTORI THERAPEUTICS +9.26% Diagnostic Substances INFINITY PHARMACEUTI +5.07% IMMUNOMEDICS INC +4.62% ORCHID CELLMARK INC +4.16% BIOSITE INC +4.02% IMMUCOR INC +3.70%…
by Andrew Vaino I’ve resisted recommending stem cell stocks. While I’m still not a huge fan of them, I think it might be worth owning at least one as part of a diversified biotech…
by H.S. AyoubBioHealth Investor The anthrax letters that contaminated the U.S. Postal Office system, and the traces of ricin found in congressional buildings had added to the mass hysteria that began on that dark…
In a sign that large pharma companies may try cooperating instead of competing as generic drug companies come for their business, AstraZeneca (AZN) and Bristol-Myers (BMY) will jointly market two new diabetes drugs. The…
Boston Scientific (BSX) is beginning to market its new drug-coated stent in Europe. After the firestorm of criticism in the US about whether drug-coated stents can cause clotting and heart problems, maybe launching overseas…
From BioHealth Investor Biotechnology IDERA PHARMACEUTICAL +13.53% RENOVIS INC +10.16% COMBINATORX +9.92% IMMUNE RESPONSE NEW +9.86% HANA BIOSCIENCES INC +8.90% Diagnostic Substances HEALTHCARE TECH LTD +26.40% RG GLBL LIFESTYLS +12.50% MONOGRAM BIOSCIENCES +9.80% ADVANCE…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotech stocks had a great day Thursday as both the Nasdaq (^NBI) and the Amex (^BTK) biotechnology indices were higher by more than 1% each. Genentech (DNA)…
From BioHealth Investor Biotechnology INSMED INC +22.33% LEV PHARMACEUTICALS +15.11% ACCENTIA BIOPHARMACE +11.39% NEURALSTEM INC +10.17% HEMOBIOTECH INC +8.11% Diagnostic Substances THRESHOLD PHARMACEUT +8.59% REMOTEMDX INC +8.11% PONIARD PHARMA +5.78% ORCHID CELLMARK INC +5.08%…
From BioHealth Investor In December, biopharmaceutical company Cephalon Inc. (CEPH) made the announcement that it has reduced its debt levels by exchanging a combination of cash and stock for $337 million in convertible notes.…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Both the Nasdaq (^NBI) and Amex (^BTK) biotech stock indices gained on Wednesday as biopharmaceutical and medical device stocks had a generally good day on Wall Street.…
Genentech (DNA) traded up marginally after beating expectations. The company posted $0.61 EPS vs $0.56 estimates and total product sales of $2.053 Billion; revenues were $2.714 Billion versus $2.55 Billion estimates. They forecast 2007…
From BioHealth Investor Biotechnology INNCARDIO INC +180.00% CYTRX CP +15.56% CRITICAL THERAPEUTIC +13.60% INCYTE CORP +11.01% AMERICAN ORIENTL BIO +10.00% Diagnostic Substances REMOTEMDX INC +12.17% AKORN INC +6.07% HEALTHCARE TECH LTD +4.35% ORCHID CELLMARK…
by H.S. AyoubBioHealth Investor.com The Nasdaq Biotechnology Index ( ^NBI) gained slightly on Tuesday ending the trading session at $807.34. Alnylam Pharmaceuticals (ALNY) gained almost 9% on the day after the company announced it…
VeriChip has made an amended filing on its IPO process, and this now looks closer to fruition than it has previously. The company will trade under the ticker "CHIP" on NASDAQ. Underwriters on the…